Literature DB >> 2885977

Transmission of human T cell lymphotropic virus type I by blood transfusion before and after mass screening of sera from seropositive donors.

S Kamihira, S Nakasima, Y Oyakawa, Y Moriuti, M Ichimaru, H Okuda, M Kanamura, T Oota.   

Abstract

The human T cell lymphotropic virus type I (HTLV-I) is transmitted by blood transfusions that contain cell components as one of the virus transmission modes. We carried out mass screening of sera from seropositive donors by a gelatin particle agglutination test to prevent the spread of HTLV-I by transfusion. Seroconversion rates were compared before and after screening. The results show a remarkable decrease in the rate of infection from 53.6 to 0.9%. Therefore, it is certain that screening by the agglutination method prevents the spread of HTLV-I transmission in blood transfusions.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2885977     DOI： 10.1111/j.1423-0410.1987.tb02987.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN： 0042-9007            Impact factor:   2.144


  17 in total

Review 1.  HTLV-1 infections.

Authors:  C R Bangham
Journal:  J Clin Pathol       Date:  2000-08       Impact factor: 3.411

2.  Improvement of simultaneous detection of antibodies to Gag and envelope antigens of human T-lymphotropic virus type I by western immunoblot assay.

Authors:  H Miyakoshi; M Sugimoto; H Igarashi; H Honda; R Fujino; M Mizukoshi
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

3.  Prevalence of human T-lymphotropic virus in civilian applicants for the United States Armed Forces.

Authors:  C R Roberts; D R Fipps; J F Brundage; S E Wright; M Goldenbaum; S S Alexander; D S Burke
Journal:  Am J Public Health       Date:  1992-01       Impact factor: 9.308

4.  Detection of human T-cell leukemia virus type I (HTLV-I) provirus in an infected cell line and in peripheral mononuclear cells of blood donors by the nested double polymerase chain reaction method: comparison with HTLV-I antibody tests.

Authors:  C Matsumoto; S Mitsunaga; T Oguchi; Y Mitomi; T Shimada; A Ichikawa; J Watanabe; K Nishioka
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

5.  Transmission of human T-cell leukemia virus type 1 to mice.

Authors:  J Fang; S Kushida; R Feng; M Tanaka; T Kawamura; H Abe; N Maeda; M Onobori; M Hori; K Uchida; M Miwa
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

6.  Screening for human T cell leukaemia/lymphoma virus among blood donors in Sweden: cost effectiveness analysis.

Authors:  E Tynell; S Andersson; E Lithander; M Arneborn; J Blomberg; H B Hansson; A Krook; M Nomberg; K Ramstedt; A Shanwell; A Bjorkman
Journal:  BMJ       Date:  1998-05-09

Review 7.  Human T-lymphotropic virus type I (HTLV-I) and tropical spastic paraparesis or HTLV-I-associated myelopathy in Hawaii.

Authors:  P S Dixon; A J Bodner; M Okihiro; A Milbourne; A Diwan; J M Nakamura
Journal:  West J Med       Date:  1990-03

8.  Post-transplantation HTLV-1 myelopathy in three recipients from a single donor.

Authors:  J J Zarranz Imirizaldu; J C Gomez Esteban; I Rouco Axpe; T Perez Concha; F Velasco Juanes; I Allue Susaeta; J M Corral Carranceja
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-08       Impact factor: 10.154

9.  Comparative studies of commercially available particle agglutination assay and enzyme-linked immunosorbent assay for screening of human T-cell leukemia virus type I antibodies in blood donors.

Authors:  S Kobayashi; T Yoshida; Y Hiroshige; T Matsui; N Yamamoto
Journal:  J Clin Microbiol       Date:  1988-02       Impact factor: 5.948

10.  Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis.

Authors:  Yoshihisa Yamano; Tomoo Sato
Journal:  Front Microbiol       Date:  2012-11-09       Impact factor: 5.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.